You are here

  • Home
  • Archive
  • Volume 21, Issue Suppl 1
  • GM-010 Sugammadex compared with suxamethonium/neostigmine/atropine for routine reversal of neuromuscular block in bariatric surgery: What’s the budget impact?

Article info

Article menu
Download PDFPDF
General Management
GM-010 Sugammadex compared with suxamethonium/neostigmine/atropine for routine reversal of neuromuscular block in bariatric surgery: What’s the budget impact?

Authors

Citation

Grande M, Descout J, Kouyoumdjian V, et al
GM-010 Sugammadex compared with suxamethonium/neostigmine/atropine for routine reversal of neuromuscular block in bariatric surgery: What’s the budget impact?
European Journal of Hospital Pharmacy 2014;21:A117-A118.

Publication history

  • First published February 24, 2014.
Online issue publication 
March 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions